Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
Episomal-Persistent DNA in Cancer- and Chronic Diseases

Research Group Episomal-Persistent DNA in Cancer- and Chronic Diseases

Dr. Timo Bund

© dkfz.de

Despite significant progress in cancer therapy, the lack of etiologic understanding in cancer causation and immunology, including synergistic (infectious) risk factors expected for >50% of cancers, limits current transfer from basic research to real-world application. As a continuation of the division of Harald zur Hausen, our group focuses on the interplay between Bovine Meat and Milk Factors (BMMF, more than 200 of such single-stranded, plasmid-like DNA elements are currently known) taken up by consumption of bovine nutrition products and the contribution to indirect induction of different types of cancer (pathologic model of ‘BMMF-induced zoonotic-linked, infectious, indirect carcinogenesis’) based on chronic inflammation (CI), induction of radicals and random DNA mutations. We also focus on BMMF in the context of chronic diseases of the human brain CNS. We apply both BMMF type-specific, ultrasensitive wet-lab as well as large-scale multi-omics in silico BMMF screening of publicly available DNA/RNA libraries to investigate the presence of BMMF as pathogenic risk factor in human cancer and in natural bio-reservoirs. In preclinical BMMF in vitro models, we test replication, transcription and expression of BMMF targets with the aim to generate and validate tools for BMMF detection and modulation of BMMF positivity.

More than 14 intensively-tested, DKFZ-built antibodies directed against a conserved BMMF protein (Rep) are used in streamlined, histochemical lab-based analysis pipelines in colorectal cancer (CRC), but also in lung, liver, pancreas and prostate cancer, amongst others, to assess diagnostic use and cancer-specific BMMF expression levels in CI-linked cancers and their (possible) inflammatory pre-cancer stages (e.g. diverticulitis, pancreatitis, non-alcoholic steatohepatitis (NASH), chronic obstructive pulmonary disease (COPD)). Causative contribution of BMMF to cancer, in particular to CRC, is assessed in histochemistry in a case vs. control and metric setup including pre-cancerous stages accessible via our broad clinical cooperation network. We combine it with additional protein-specific (immunoblotting and mass spectroscopy) and DNA/RNA-based readouts (qPCR/PCR, NGS, laser microdissection). In addition, we focus on the prognostic relevance of BMMF expression based on an immunoreactive BMMF score to evaluate BMMF expression in tumour and peritumour tissues and the associated outcome. We complement that with bulk as well as single-cell RNAseq large data analyses to test the effect of BMMF expression on the regulation of BMMF-positive macrophages to unravel the molecular and mechanistical background of BMMF-driven indirect carcinogenesis. This also includes the pro-tumourigenic modulation of the tumor microenvironment (TME) and therapy resistance, which might be supported by BMMF. We analyze the ultrastructure of BMMF targets (by immuno electron microscopy), which suggests a pleomorphic, vesicular presence of BMMF and accessibility for intervention - e.g. based on antibodies.

Our multi-omics read outs are steadily revised and expanded for new targets to unravel the role of BMMF in indirect carcinogenesis, which most likely represent one of the most common zoonotic-linked infections in humans. We expect a penetration of BMMF into 30-50% of current cancer cases and 40-60% of cancer deaths.

To foster cancer prevention based on BMMF technology, we analyze the effects of BMMF exposure in pre-clinical models (BMMF mouse model, cell (co-)culture models). Our vision is to establish early cancer diagnosis and systemic and/or BMMF antibody and immune cell therapy to reduce the burden of BMMF and to prevent/therapize BMMF-linked cancer.

Contact

Dr. Timo Bund
Episomal-Persistent DNA in Cancer- and Chronic Diseases (D460)
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg
Tel: +49 6221 42 4655

Selected Publications

  • Nikitina, E., Alikhanyan, K., Nessling, M., Richter, K., Kaden, S., Ernst, C., Seitz, S., Chuprikova, L., Haefele, L., Gunst, K., Rahbari, N., Birgin, E., Rasbach, E., Rahbari, M., Brobeil, A., Schenk, M., Büchler, M., de Villiers, E.-M., Bund, T.*, zur Hausen, H. Structural Expression of BMMF in tissues of colorectal, lung and pancreatic cancer patients, Int J Cancer, 2022. (*correspondence) DOI: 10.1002/ijc.34374
  • Bund, T., Nikitina, E., Chakraborty, D., Ernst, C., Gunst, K., Boneva, B., Tessmer, T., Volk, N., Brobeil, A., Weber, A., Heikenwalder, M., zur Hausen, H., de Villiers, E.-M. Chronic Inflammatory Lesions of the Colon for BMMF Rep Antigen Expression and CD68 Macrophage Interactions, Proc Natl Acad Sci U S A 118(12):e2025830118, 2021. DOI: 10.1073/pnas.2025830118
  • zur Hausen, H., de Villiers, E.-M., Bovine Meat and Milk Factors (BMMFs): Their Proposed Role in Common Human Cancers and Type 2 Diabetes Mellitus, Cancers 13(21):5407, 2021. DOI: 10.3390/cancers13215407
  • Eilebrecht, S., Hotz-Wagenblatt, A., Sarachaga, V., Burk, A., Falida, K., Chakraborty, D., Nikitina, E., Tessmer, C., Whitley, C., Sauerland, C., Gunst, K., Grewe, I., Bund, T., Expression and replication of virus-like circular DNA in human cells, Scientific Reports, 8:2851, 2018. DOI: 10.1038/s41598-018-21317-w
to top
powered by webEdition CMS